• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有血管侵犯的肾细胞癌:死亡率及预后因素。

Renal cell carcinoma with vascular invasion: Mortality and prognostic factors.

作者信息

Rodríguez-Cabello M A, Laso-García I, Donis-Canet F, Gómez-Dos-Santos V, Varona-Crespo C, Burgos-Revilla F J

机构信息

Servicios de Urología, Hospital Universitario Ramón y Cajal, Madrid, España.

Servicios de Urología, Hospital Universitario Ramón y Cajal, Madrid, España.

出版信息

Actas Urol Esp. 2017 Mar;41(2):132-138. doi: 10.1016/j.acuro.2016.06.007. Epub 2016 Jul 25.

DOI:10.1016/j.acuro.2016.06.007
PMID:27461850
Abstract

OBJECTIVE

Analysis of the results of patients who had been operated of renal cell carcinoma with vascular invasion in our institution, evaluation of prognostic factors and complications.

METHODS

Retrospective observational study of 37 patients diagnosed of renal cell carcinoma with vascular invasion operated between May 1999 and July 2013. We used the method of Kaplan-Meier survival analysis and the Mantel-Haenszel's test (log rank) and the Cox's proportional hazards analysis test to analyse the risk factors of mortality.

RESULTS

The median age was 60 years. Mean follow-up period was 42.1 months. The median overall survival and disease-free survival were 53.8and 36.3 months, respectively. There was statistical association between overall survival and ASA (p=0.047), tumor stage (p=0.003), lymph node involvement (p=0.024), presence of metastases (p=0.013), level of tumor thrombus (p=0, 05) and histological type (p=0.001). 14 patients had grade IIIb complications or higher according to the Clavien Dindo classification, the most frequent was bleeding.

CONCLUSIONS

Renal cell carcinoma with vascular invasion is a disease with high rate of mortality. Surgery is a therapeutic option that can be curative. The number of complications is important. Survival is conditioned by the ASA, tumor stage, the level of tumor thrombus, lymph node involvement, metastasis and histological type.

摘要

目的

分析我院接受肾细胞癌伴血管侵犯手术患者的结果,评估预后因素及并发症。

方法

对1999年5月至2013年7月间接受手术的37例诊断为肾细胞癌伴血管侵犯的患者进行回顾性观察研究。我们采用Kaplan-Meier生存分析方法、Mantel-Haenszel检验(对数秩检验)和Cox比例风险分析检验来分析死亡风险因素。

结果

中位年龄为60岁。平均随访期为42.1个月。中位总生存期和无病生存期分别为53.8个月和36.3个月。总生存期与美国麻醉医师协会分级(ASA)(p = 0.047)、肿瘤分期(p = 0.003)、淋巴结受累情况(p = 0.024)、转移情况(p = 0.013)、肿瘤血栓水平(p = 0.05)及组织学类型(p = 0.001)之间存在统计学关联。根据Clavien Dindo分类,14例患者出现IIIb级或更高级别的并发症,最常见的是出血。

结论

肾细胞癌伴血管侵犯是一种死亡率较高的疾病。手术是一种可能治愈的治疗选择。并发症的数量不容忽视。生存情况受ASA分级、肿瘤分期、肿瘤血栓水平、淋巴结受累情况、转移情况及组织学类型的影响。

相似文献

1
Renal cell carcinoma with vascular invasion: Mortality and prognostic factors.伴有血管侵犯的肾细胞癌:死亡率及预后因素。
Actas Urol Esp. 2017 Mar;41(2):132-138. doi: 10.1016/j.acuro.2016.06.007. Epub 2016 Jul 25.
2
Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma.微血管侵犯在预测肾细胞癌生存中的预后价值。
Actas Urol Esp. 2013 Sep;37(8):504-12. doi: 10.1016/j.acuro.2012.07.008. Epub 2013 Apr 23.
3
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
4
Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.对于临床无转移的肾细胞癌,显微镜下血管侵犯是根治性肾切除术后最重要的预后指标。
J Urol. 1997 Jul;158(1):45-9. doi: 10.1097/00005392-199707000-00013.
5
Prognostic factors for renal cell carcinoma with tumor thrombus extension.伴有肿瘤血栓延伸的肾细胞癌的预后因素
J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195. doi: 10.1016/j.juro.2007.05.134. Epub 2007 Aug 14.
6
Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.微血管侵犯对预测肾细胞癌患者肿瘤特异性生存和转移风险的预后价值:一项多中心研究。
J Urol. 2012 Feb;187(2):418-23. doi: 10.1016/j.juro.2011.10.024. Epub 2011 Dec 15.
7
[Pathological prognostic indicators in renal cell carcinoma].[肾细胞癌的病理预后指标]
Actas Urol Esp. 2010 Jan;34(1):71-7.
8
Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.中国肾细胞癌伴静脉瘤栓延伸患者的临床和肿瘤学结局:单中心经验
World J Surg Oncol. 2015 Feb 4;13:14. doi: 10.1186/s12957-015-0448-2.
9
[Prognostic value of venous tumor thrombus in renal cell carcinoma].[肾细胞癌中静脉瘤栓的预后价值]
Actas Urol Esp. 2012 Jan;36(1):29-34. doi: 10.1016/j.acuro.2011.06.002. Epub 2011 Jul 30.
10
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.血管切缘阳性对pT3期透明细胞肾细胞癌的预后影响
J Urol. 2016 Feb;195(2):264-9. doi: 10.1016/j.juro.2015.08.099. Epub 2015 Sep 10.

引用本文的文献

1
Renal cell carcinoma as a cause of aortic tumor thrombus embolization and acute limb ischemia.肾细胞癌作为主动脉瘤血栓栓塞和急性肢体缺血的病因。
J Vasc Surg Cases Innov Tech. 2024 Aug 6;10(6):101594. doi: 10.1016/j.jvscit.2024.101594. eCollection 2024 Dec.
2
Oncologic Outcomes and Predictors in Patients with Stage PT3aNxM0 Renal Cell Carcinoma Following Radical Nephrectomy.根治性肾切除术后PT3aNxM0期肾细胞癌患者的肿瘤学结局及预测因素
Urol Res Pract. 2023 Jan;49(1):25-32. doi: 10.5152/tud.2023.22072.
3
The Impact of Frailty on Morbidity and Mortality following Open Emergent Colectomies.
虚弱对开放性急诊结肠切除术术后发病率和死亡率的影响。
Biomed Res Int. 2017;2017:5126452. doi: 10.1155/2017/5126452. Epub 2017 Sep 6.
4
Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.E-钙黏蛋白减少通过激活WNT/β-连环蛋白信号通路促进肾细胞癌进展。
Oncotarget. 2017 Mar 21;8(12):19566-19576. doi: 10.18632/oncotarget.15361.